THE PHASE 2 VERACEPT (TM) INTRAUTERINE CONTRACEPTIVE TRIAL: 36-MONTH EFFICACY, SAFETY, AND TOLERABILITY OUTCOMES

Turok D.; Dart C.; Schreiber C.; Nelson A.

首页> 外文期刊>Contraception >THE PHASE 2 VERACEPT (TM) INTRAUTERINE CONTRACEPTIVE TRIAL: 36-MONTH EFFICACY, SAFETY, AND TOLERABILITY OUTCOMES

【24h】

THE PHASE 2 VERACEPT (TM) INTRAUTERINE CONTRACEPTIVE TRIAL: 36-MONTH EFFICACY, SAFETY, AND TOLERABILITY OUTCOMES

机译：第2阶段验证（TM）宫内避孕药：36个月的疗效，安全性和可耐受性结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Contraception》 |2019年第4期|共1页
作者
Turok D.; Dart C.; Schreiber C.; Nelson A.;
展开▼
作者单位

Univ Utah Family Planning Div Salt Lake City UT USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类个人卫生;
关键词

相似文献

外文文献
中文文献
专利

1. THE PHASE 2 VERACEPT (TM) INTRAUTERINE CONTRACEPTIVE TRIAL: 36-MONTH EFFICACY, SAFETY, AND TOLERABILITY OUTCOMES [J] . Turok D., Dart C., Schreiber C., Contraception . 2019,第4期

机译：第2阶段验证（TM）宫内避孕药：36个月的疗效，安全性和可耐受性结果
2. Phase 2 efficacy, safety and tolerability results of the veracept low-dose copper intrauterine contraceptive: 24-month data [J] . Turok D., Nelson A. Contraception . 2018,第4期

机译：阶段2疗效，安全性和可耐受性的低剂量铜宫内避孕药避孕药：24个月数据
3. Multicenter, phase III III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill [J] . Palacios Santiago, Colli Enrico, Regidor Pedro‐Antonio Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi . 2019,第12期

机译：多中心，第III期III试验对避孕药的避孕效果，可耐受性和安全性的唯一唯一的卓越龙酮药丸
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Efficacy, Tolerability and Safety of Operating Room Microlaryngoscopy Versus Office-Based Potassium Titanyl Phosphate (KTP) Laser Treatment of Benign Vocal Fold Lesions: A Longitudinal Prospective Evaluation of Multidimensional Voice Outcomes [D] . Chadwick, Keith Alan. 2020

机译：手术室微淋镜检查的功效，耐受性和安全性与良性声带病变的基于办事处的磷酸钾（KTP）激光治疗：多维语音结果的纵向前瞻性评估
6. The Effect of Age Parity and Body Mass Index on the Efficacy Safety Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial [O] . Kristina Gemzell-Danielsson, Dan Apter, Brian Hauck, -1

机译：年龄奇偶性和体重指数对与两种低剂量左炔诺孕酮宫内避孕系统相关的功效安全性位置和用户满意度的影响：来自第三阶段试验的数据的亚组分析
7. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial. [O] . Kristina Gemzell-Danielsson, Dan Apter, Brian Hauck, 2015

机译：年龄，平等和体重指数对两种低剂量左炔诺孕酮宫内避孕系统相关的疗效，安全性，安置和使用者满意度的影响：来自III期试验的数据的亚组分析。

THE PHASE 2 VERACEPT (TM) INTRAUTERINE CONTRACEPTIVE TRIAL: 36-MONTH EFFICACY, SAFETY, AND TOLERABILITY OUTCOMES

著录项

引文网络

相似文献

相关主题

期刊订阅